Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Silo Pharma Inc (NQ: SILO )

2.260 +1.190 (+111.21%)
Streaming Delayed Price Updated: 3:09 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 155,080,361
Open 2.270
Bid (Size) 2.250 (72)
Ask (Size) 2.260 (28)
Prev. Close 1.070
Today's Range 1.880 - 2.600
52wk Range 0.8410 - 3.050
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views
Via Benzinga
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Performance

YTD
+48.68%
+48.68%
1 Month
+115.28%
+115.28%
3 Month
+18.95%
+18.95%
6 Month
+56.67%
+56.67%
1 Year
+10.78%
+10.78%

More News

Read More
Crude Oil Down 1%; Bank of America Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Why Is Silo Pharma (SILO) Stock Up 123% Today?
Via InvestorPlace
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Exclusive Global License to Develop, Manufacture, Commercialize Alzheimer Drug
Via Investor Brand Network
Why Is Nano-Cap Silo Pharma Stock Skyrocketing On Tuesday?
Via Benzinga
Exposures Product Safety
Dow Jumps 400 Points; US Retail Sales Flat For June
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Greenpro Capital (GRNQ) Stock Down 19% Today?
Via InvestorPlace
Why Is Autonomix Medical (AMIX) Stock Down 17% Today?
Via InvestorPlace
Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters License Agreement with Columbia University for Lead Candidate Targeting PTSD, Stress-Induced Anxiety Disorders
Via Investor Brand Network
Exposures Product Safety
Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Collaborates with CRO Partner to Advance SPC-15 for PTSD
Via Investor Brand Network
Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety
From Silo Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes on $2M Registered Direct Offering, Provides Update on SP-26 Ketamine Implant Therapeutic
Via Investor Brand Network
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia
From Silo Pharma, Inc.
Via GlobeNewswire
Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From Silo Pharma, Inc.
Via GlobeNewswire
Crude Oil Rises 1%; Dollar Tree Shares Fall After Q1 Results
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Enters Registered Direct Offering Estimated to Reach $2M
Via Investor Brand Network
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Gold Gains 1%; ISM Services PMI Surges In May
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.